Clinical Trials

60,300 enrolled

Colorectal Neoplasms

NCT03568188 2026-02-24

FOCALE

Phase 2 Completed

174 enrolled

Genitourinary

Prostatic Neoplasms

NCT06346054 2026-02-17

MAGEC

1,000 enrolled

Barrett Esophagus, Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT05848050 2025-11-24

METALIQ

21 enrolled

CNS

Brain Neoplasms

NCT04424719 2025-09-03

SALOME

700 enrolled

Dermatologic

Uveal Melanoma

NCT06989814 2025-08-11

SMART

50 enrolled

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

NCT06620835 2025-07-29

OPTALK

Phase 2 Recruiting

45 enrolled

Phase NA Not yet recruiting

Lung Neoplasms

NCT06999785 2025-05-31

OXYBAR

60 enrolled

Tumor-Agnostic

Neoplasms

NCT06929481 2025-05-02

Screening With a DNA Blood Test to Address Colorectal Cancer Inequities

Phase NA Enrolling by invitation

340 enrolled

Colorectal Neoplasms

NCT04871490 2025-02-05

IDEA-HPV

Phase NA Active not recruiting

40 enrolled

Head & Neck

HPV Positive Oropharyngeal Squamous Cell Carcinoma

NCT06730035 2024-12-12

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

30 enrolled

Rectal Neoplasms

NCT06454071 2024-06-12

Immunologic Changes and Recovery-related Factors in Elderly Colon Cancer Patients

Phase 2 Completed

75 enrolled

Colonic Neoplasms

NCT05766046 2024-03-26

RISP

7,324 enrolled

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT02310451 2023-09-08

EXOSOMES

15 enrolled

Dermatologic

Melanoma

NCT05188755 2022-12-23

CUPCAKE

44 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin, Motor Activity

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Phase 2 Completed

22 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

886 enrolled

Recurrence, Stomach Neoplasms

NCT03645317 2021-08-02

ACCOLADE

200 enrolled

Lung Neoplasms

NCT04168788 2019-11-19

MVO

Classical hematologyGenitourinaryLymphoidOther hematologic neoplasm

150 enrolled

Hepatic Veno-Occlusive Disease, Wilms Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02839681 2019-05-21

Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma

Phase 2 Terminated

2 enrolled 12 charts

Adenocarcinoma of Lung, Lung Neoplasms

NCT01604642 2018-04-02

Role of Activin A (ActA) in the Human Cancer Cachexia

150 enrolled

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms

NCT01834950 2018-03-29

HERBIN

25 enrolled

Breast

Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer

NCT02610764 2017-04-13

ESO-CTC

19 enrolled

Adenocarcinoma Of Esophagus, Neoplastic Cells, Circulating

NCT02560571 2016-09-20

Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients

Phase 2 Unknown

200 enrolled

Gynecologic

Endometrial Neoplasms

NCT02747563 2016-04-21

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Phase 1 Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT01608919 2015-08-10

Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection

Phase NA Terminated

4 enrolled

Classical hematology

Venous Thromboembolism

NCT01492127 2015-04-23

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

64 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT02288078 2014-11-13

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Phase 2 Unknown

74 enrolled

Fatigue, Rectal Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Phase 2 Unknown

110 enrolled

Rectal Neoplasms

NCT00435864 2014-04-30

Natural Killer Index From Hematopoietic Stem Cell Graft

LymphoidMyeloidOther hematologic neoplasm

92 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01687647 2014-04-09

AMORCE-CBP

Phase 3 Unknown

1,000 enrolled

Lung Neoplasms

NCT02090166 2014-03-18

EDLC

950 enrolled

Lung Neoplasms

NCT00580281 2013-10-24

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors